Skip to main content

Advertisement

SpringerLink
Log in

Coccidioidomycosis in Children and Adolescents: an Update

  • Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz and M Pereira, Section Editors)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Coccidioidomycosis is a systemic fungal infection endemic in Southwestern United States, Northern Mexico, Central and South America. Coccidioidal infection is not well characterized in pediatric population; but due to an increasing incidence in this age group, a special interest had surged to further describe clinical findings, treatment and clinical course of pediatric patients with coccidioidomycosis.

Recent Findings

In the last few years new data about coccidioidomycosis in children and adolescents has been published, including the report of increasing incidence in general population, making a high index of suspicion among healthcare providers important to avoid delays in diagnosis and treatment.

Summary

This review focuses on coccidioidal infections in pediatric population, emphasizing on the epidemiology, clinical manifestations, natural history, diagnosis and management in children and adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Dimitrova D, Ross L. Coccidioidomycosis: experience from a children’s hospital in an area of endemicity. J Pediatric Infect Dis Soc. 2016;5(1):89–92. https://doi.org/10.1093/jpids/piu091This paper provides further clinical characterization of children with coccidioidomycosis by describing experience with 64 patients from an endemic area.

    Article  PubMed  Google Scholar 

  2. Brown J, Benedict K, Park BJ, Thompson GR 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;5:185–97. https://doi.org/10.2147/CLEP.S34434.

    Article  PubMed  PubMed Central  Google Scholar 

  3. McCarty JM, Demetral LC, Dabrowski L, Kahal AK, Bowser AM, Hahn JE. Pediatric coccidioidomycosis in central California: a retrospective case series. Clin Infect Dis. 2013;56(11):1579–85. https://doi.org/10.1093/cid/cit114.

    Article  PubMed  Google Scholar 

  4. Nimer N, Camp T. Coccidioidomycosis. Pediatr Rev. 2015;36(4):181–2. https://doi.org/10.1542/pir.36-4-181.

    Article  PubMed  Google Scholar 

  5. •• Lee LA, Sondermeyer Cooksey GL, Kim JJ, Kahal A, Gilliss D, Naeem F, et al. Pediatric coccidioidomycosis: case series from a California pediatric infectious diseases clinic. Pediatr Infect Dis J. 2019;38(2):115–21. https://doi.org/10.1097/INF.0000000000002069This paper amply describes clinical findings, diagnosis, and management of coccidioidomycosis in 108 pediatric patients from an endemic area.

    Article  PubMed  Google Scholar 

  6. • Shehab ZM. Coccidioidomycosis. Adv Pediatr. 2010;57(1):269–86. https://doi.org/10.1016/j.yapd.2010.08.008This paper provides general information of coccidioidomycosis in pediatric population.

    Article  PubMed  Google Scholar 

  7. Stockamp NW, Thompson GR 3rd. Coccidioidomycosis. Infect Dis Clin N Am. 2016;30(1):229–46. https://doi.org/10.1016/j.idc.2015.10.008.

    Article  Google Scholar 

  8. •• Sondermeyer Cooksey GL, Jain S, Vugia DJ. Epidemiology of coccidioidomycosis among children in California, 2000-2016. Med Mycol. 2019;57(Supplement_1):S64–6. https://doi.org/10.1093/mmy/myy066This paper reports the latest epidemiology data of coccidioidomycosis in the California pediatric population.

    Article  PubMed  Google Scholar 

  9. •• OZ MC, Benedict K, Engelthaler DM, Komatsu K, Lucas KD, Mohle-Boetani JC, et al. Update on the epidemiology of coccidioidomycosis in the United States. Med Mycol. 2019;57(Supplement_1):S30–40. https://doi.org/10.1093/mmy/myy095This paper provides an update on coccidioidomycosis recent trends and public health efforts nationally and in Arizona, California, and Washington states.

    Article  Google Scholar 

  10. • Benedict K, Ireland M, Weinberg MP, Gruninger RJ, Weigand J, Chen L, et al. Enhanced surveillance for coccidioidomycosis, 14 US states, 2016. Emerg Infect Dis. 2018;24(8):1444–52. https://doi.org/10.3201/eid2408.171595This paper describes the epidemiology, diagnosis, and outcomes of coccidioidomycosis in non-highly endemic states of the USA.

    Article  PubMed  PubMed Central  Google Scholar 

  11. • Luo R, Greenberg A, Stone CD. Hospitalized burden and outcomes of coccidioidomycosis: a nationwide analysis, 2005-2012. Med Mycol. 2017;55(4):368–74. https://doi.org/10.1093/mmy/myw087This paper reviews the outcomes of coccidioidomycosis, such as trends of annual hospitalization, in-hospital mortality, and independent risk factors for mortality.

    Article  PubMed  Google Scholar 

  12. Forrester JD, Guo HH, Weiser TG. Coccidioidomycosis: surgical issues and implications. Surg Infect. 2016;17(6):645–55. https://doi.org/10.1089/sur.2016.148.

    Article  Google Scholar 

  13. Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9(1):1426–35. https://doi.org/10.1080/21505594.2018.1509667.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fisher BT, Chiller TM, Prasad PA, Beveridge M, Walsh TJ, Zaoutis TE. Hospitalizations for coccidioidomycosis at forty-one children’s hospitals in the United States. Pediatr Infect Dis J. 2010;29(3):243–7. https://doi.org/10.1097/INF.0b013e3181bcfd7f.

    Article  PubMed  Google Scholar 

  15. Connelly MB, Zerella JT. Surgical management of coccidioidomycosis in children. J Pediatr Surg. 2000;35(11):1633–4. https://doi.org/10.1053/jpsu.2000.

    Article  CAS  PubMed  Google Scholar 

  16. Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–5. https://doi.org/10.1086/500405.

    Article  PubMed  Google Scholar 

  17. • Laniado-Laborín R, Arathoon EG, Canteros C, Muñiz-Salazar R, Rendon A. Coccidioidomycosis in Latin America. Med Mycol. 2019;57(Supplement_1):S46–55. https://doi.org/10.1093/mmy/myy037This paper provides information of coccidioidomycosis in Latin America.

    Article  PubMed  Google Scholar 

  18. Bonifaz-Trujillo JA. In: Bonifaz-Trujillo JA, editor. Coccidioidomycosis, Micología médica básica: McGraw-Hill; 2015.

  19. Castro-Lopez N, Hung CY. Immune response to coccidioidomycosis and the development of a vaccine. Microorganisms. 2017;5(1):E13. https://doi.org/10.3390/microorganisms5010013.

    Article  CAS  PubMed  Google Scholar 

  20. •• Hung CY, Hsu AP, Holland SM, Fierer J. A review of innate and adaptive immunity to coccidioidomycosis. Med Mycol. 2019;57(Supplement_1):S85–92. https://doi.org/10.1093/mmy/myy146This review discusses features of the immune response and genetic susceptibility toCoccidioidessp. infection.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. •• Blair JE, Ampel NM, Hoover SE. Coccidioidomycosis in selected immunosuppressed hosts. Med Mycol. 2019;57(Supplement_1):S56–63. https://doi.org/10.1093/mmy/myy019This paper summarizes the clinical manifestations, diagnosis, treatment, and prevention of coccidioidomycosis in immunosuppressed hosts.

    Article  PubMed  Google Scholar 

  22. • Odio CD, Marciano BE, Galgiani JN, Holland SM. Risk factors for disseminated coccidioidomycosis, United States. Emerg Infect Dis. 2017;23(2). https://doi.org/10.3201/eid2302.160505This paper reviews the risk factors for disseminated coccidioidomycosis.

  23. Noble JA, Nelson RG, Fufaa GD, Kang P, Shafir SC, Galgiani JN. Effect of geography on the analysis of coccidioidomycosis-associated deaths, United States. Emerg Infect Dis. 2016;22(10):1821–3. https://doi.org/10.3201/eid2210.160696.

    Article  PubMed  PubMed Central  Google Scholar 

  24. •• Naeem F, McCarty J, Mhaissen MN, Ha S, Rongkavilit C. Extrapulmonary coccidioidomycosis among children in Central California: a retrospective review. Pediatr Infect Dis J. 2019;38(12):1189–94. https://doi.org/10.1097/INF.0000000000002470This retrospective review provides good information about the clinical course, diagnostic studies, treatment, and outcomes of 78 children with extrapulmonary coccidioidomycosis.

    Article  PubMed  Google Scholar 

  25. Garcia Garcia SC, Salas Alanis JC, Flores MG, Gonzalez Gonzalez SE, Vera Cabrera L, Ocampo CJ. Coccidioidomycosis and the skin: a comprehensive review. An Bras Dermatol. 2015;90(5):610–9. https://doi.org/10.1590/abd1806-4841.20153805.

    Article  PubMed  Google Scholar 

  26. Yeoh DK, Butters C, Curtis N. Endemic mycoses in children. Pediatr Infect Dis J. 2019;38(6S Suppl 1):S52–9. https://doi.org/10.1097/INF.0000000000002324.

    Article  PubMed  Google Scholar 

  27. Rojas-García OC, Moreno-Treviño MG, Gonzalez-Salazar F, Salas-Alanis JC. Primary cutaneous coccidioidomycosis in an infant. Gac Med Mex. 2014;150(2):175–6.

    PubMed  Google Scholar 

  28. Abdelmisseh M, Naeem F, Veesenmeyer A, Siongco A, Rongkavilit C. A California infant with insidious left wrist swelling. Pediatr Infect Dis J. 2018;37(6):615. https://doi.org/10.1097/INF.0000000000001858.

    Article  PubMed  Google Scholar 

  29. Escobedo EV, Ho CH, Homans JD. An 18-year-old man with bilateral violaceous cervical adenopathy. JAMA Pediatr. 2014;168(8):773–4. https://doi.org/10.1001/jamapediatrics.2013.4656.

    Article  PubMed  Google Scholar 

  30. McHardy IH, Dinh BN, Waldman S, Stewart E, Bays D, Pappagianis D, et al. Coccidioidomycosis complement fixation titer trends in the age of antifungals. J Clin Microbiol. 2018;56(12):e01318. https://doi.org/10.1128/JCM.01318-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gabe LM, Malo J, Knox KS. Diagnosis and management of coccidioidomycosis. Clin Chest Med. 2017;38(3):417–33. https://doi.org/10.1016/j.ccm.2017.04.005.

    Article  PubMed  Google Scholar 

  32. Brennan-Krohn T, Yoon E, Nishino M, Kirby JE, Riedel S. Arthroconidia in lung tissue: an unusual histopathological finding in pulmonary coccidioidomycosis. Hum Pathol. 2018;71:55–9. https://doi.org/10.1016/j.humpath.2017.07.013.

    Article  PubMed  Google Scholar 

  33. • Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112–46. https://doi.org/10.1093/cid/ciw360These revised guidelines provide recommendations for diagnosis and management of coccidioidal infections.

    Article  PubMed  Google Scholar 

  34. Levy ER, McCarty JM, Shane AL, Weintrub PS. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis. 2013;56(11):1573–8. https://doi.org/10.1093/cid/cit113.

    Article  CAS  PubMed  Google Scholar 

  35. Homans JD, Spencer L. Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature. Pediatr Infect Dis J. 2010;29(1):65–7.

    Article  Google Scholar 

  36. Ho AK, Shrader MW, Falk MN, Segal LS. Diagnosis and initial management of musculoskeletal coccidioidomycosis in children. J Pediatr Orthop. 2014;34(5):571–7. https://doi.org/10.1097/BPO.0000000000000147.

    Article  PubMed  Google Scholar 

  37. Krogstad P, Johnson R, Garcia-Lloret MI, Heidari A, Butte MJ. Host-pathogen interactions in coccidioidomycosis: prognostic clues and opportunities for novel therapies. Clin Ther. 2019;41(10):1939–1954.e1. https://doi.org/10.1016/j.clinthera.2019.08.011.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, National Institute of Pediatrics, Insurgentes Sur 3700C, 04530, Mexico City, Mexico

    Mariana Maza-Morales, Marian Kristalia Rivas-Calderón, Elsa Eduwiges Barrón-Calvillo & Maria Teresa García-Romero

Authors
  1. Mariana Maza-Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marian Kristalia Rivas-Calderón
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elsa Eduwiges Barrón-Calvillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Teresa García-Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Teresa García-Romero.

Ethics declarations

Conflict of Interest

Maria Teresa Garcia-Romero reports personal fees from Pierre Fabre Mexico, personal fees from Sanofi Mexico, and personal fees from Pfizer Mexico outside the submitted work. Mariana Maza-Morales, Marian Kristalia Rivas-Calderón and Elsa Eduwiges Barrón-Calvillo declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Fungal Infections of Skin and Subcutaneous Tissue

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maza-Morales, M., Rivas-Calderón, M.K., Barrón-Calvillo, E.E. et al. Coccidioidomycosis in Children and Adolescents: an Update. Curr Fungal Infect Rep 14, 106–114 (2020). https://doi.org/10.1007/s12281-020-00381-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-020-00381-8

Keywords

Search

Navigation